Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sensi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Neurology|August 4, 1999
Systemic sclerosis and multiple sclerosisA Spadaro, F Sensi, M Barrella, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 11, 2001
Ultrasound measurements at the proximal phalanges in male patients with psoriatic arthritisE Taccari, F Sensi, A Spadaro, et al.
Revue Du Rhumatisme (English Ed.)|January 29, 1999
Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritisE Taccari, A Spadaro, T Rinaldi, et al.
Clinical and Experimental Rheumatology|January 28, 1998
Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugsA Spadaro, E Taccari, B Mohtadi, et al.
Clinical Rheumatology|May 20, 1998
Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritisA Spadaro, E Taccari, F Sensi, et al.
Clinical and Experimental Rheumatology|September 1, 1995
Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective studyA Spadaro, V Riccieri, A Sili-Scavalli, et al.
Clinical Rheumatology|March 1, 1996
Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritisA Spadaro, V Riccieri, A Sili Scavalli, et al.
Clinical and Experimental Rheumatology|July 1, 1996
Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parametersA Spadaro, E Taccari, V Riccieri, et al.
Revue Du Rhumatisme (English Ed.)|February 1, 1997
Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritisA Spadaro, E Taccari, V Riccieri, et al.
Revue Du Rhumatisme (English Ed.)|March 1, 1996
Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parametersA Spadaro, V Riccieri, A Sili Scavalli, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Neurology|August 4, 1999
Systemic sclerosis and multiple sclerosisA Spadaro, F Sensi, M Barrella, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 11, 2001
Ultrasound measurements at the proximal phalanges in male patients with psoriatic arthritisE Taccari, F Sensi, A Spadaro, et al.
Revue Du Rhumatisme (English Ed.)|January 29, 1999
Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritisE Taccari, A Spadaro, T Rinaldi, et al.
Clinical and Experimental Rheumatology|January 28, 1998
Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugsA Spadaro, E Taccari, B Mohtadi, et al.
Clinical Rheumatology|May 20, 1998
Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritisA Spadaro, E Taccari, F Sensi, et al.
Clinical and Experimental Rheumatology|September 1, 1995
Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective studyA Spadaro, V Riccieri, A Sili-Scavalli, et al.
Clinical Rheumatology|March 1, 1996
Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritisA Spadaro, V Riccieri, A Sili Scavalli, et al.
Clinical and Experimental Rheumatology|July 1, 1996
Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parametersA Spadaro, E Taccari, V Riccieri, et al.
Revue Du Rhumatisme (English Ed.)|February 1, 1997
Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritisA Spadaro, E Taccari, V Riccieri, et al.
Revue Du Rhumatisme (English Ed.)|March 1, 1996
Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parametersA Spadaro, V Riccieri, A Sili Scavalli, et al.
Pageof 2